Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)
SIGES-01
A Prospective Cohort Study of Early Detection and Screening Strategy for Gatric Cancer in Sichuan Province China (SIGES-01)
2 other identifiers
observational
30,000
1 country
1
Brief Summary
To establish prospective cohort of healthy population and corresponding serum sample bank in Sichuan province to provide platform for exploring early diagnosis and screening strategy of gastric cancer by a prospective cohort study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
July 15, 2018
CompletedFirst Posted
Study publicly available on registry
July 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedJuly 24, 2018
July 1, 2018
3 years
July 15, 2018
July 15, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The number of new cases of gastric carcinoma
The new cases of gastric and other epidermal malignant tumor
5 years
Secondary Outcomes (1)
Time of finding nee cases
5 years
Eligibility Criteria
In our study, the poplatiion was enrolled among health inhabitant in Sichuan province in China. People who underwent physical examination in our center who statisfy our indications will be introdeced to participate in our study. The informed consent will be endosed and the blood sample will be collected.
You may qualify if:
- Inhabitant in Sichuan province in China (length of residence \> 10 years);
- Complete physical examination in our hospital, the outcomes was asymptomatic and cancer free healthy individuals;
- Age between 20 and 70;
- With normal cognitive and communication ability;
- Without gastroscopy during recruitment, physical examination item including gastroscopy enrolled in prospective cohort study;
- Wiling to accept 1-2 times routine physical examination in our hospital;
- Agree to accept the follow-up of our project group;
You may not qualify if:
- With history of malignant tumor;
- Refuse to donate blood specimen;
- With serious comorbidity and/or finite life (less than 5 years);
- Request to retreat from this study;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jian-Kun Hulead
- Xin-Zu Chencollaborator
Study Sites (1)
Jian-Kun Hu
Chengdu, Sichuan, 610041, China
Biospecimen
Serum samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Vice director of Gastrointestinal Surgery department, West China Hospital; Director of Institute of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital
Study Record Dates
First Submitted
July 15, 2018
First Posted
July 24, 2018
Study Start
January 1, 2017
Primary Completion
December 31, 2019
Study Completion
December 31, 2020
Last Updated
July 24, 2018
Record last verified: 2018-07